Search Tufts Medicine

Displaying 361 - 380 of 478
Giving
calendar-event February 15, 2024 clock - All day
Lowell General Hospital Auxiliary "Daffodil Day"  Beginning February 15, 2024 Pre-order bunches or potted flowers: $10 per bunch $12 per mini-potted daffodil $25 "Spreading Kindness" (gifted to a patient or support staff at the hospital) Pick up on March 21st at:
Patient Stories
March 9, 2020
When Justin Williams, 28, walked into his local emergency room in October of 2018, he was shocked to learn that the pain he was experiencing was not from the minor car accident he was in the day before. The physicians suspected cancer.
Articles
July 14, 2022
Dr. Jack Erban passed away on September 2, 2020 at the age of 65 after a yearlong battle with brain cancer. An internationally recognized oncologist, his memory lives on in the countless lives he touched and the science he helped advance.
clinical trial
...

The purpose of this study is to evaluate the safety and effectiveness of the Vanquish Water Vapor Ablation Device (“Vanquish”) in subjects with Gleason Grade Group 2 (GGG2) localized intermediate-risk prostate cancer
clinical trial
...

The purpose of this study is to describe, under real-world conditions, the safety and effectiveness of larotrectinib in patients with locally advanced or metastatic TRK fusion cancer for whom a decision to treat with larotrectinib has been made before enrollment.
Articles
November 22, 2019
More than 100 guests were treated to a night of Indian culture while raising $16,000 for cancer patients at Lowell General Hospital’s second annual Diwali Celebration on Friday, October 25 at Clark Auditorium on the hospital’s main campus.
Patient Stories
November 30, 2019
Katherine used to spend most of her day outside, but with a cancer diagnosis she wasn't able to do her everyday tasks. With the help of the Division of Palliative Care, Katherine is back outside with her grandchildren.
page
...
The faculty in the Division of Endocrinology, Diabetes and Metabolism at Tufts Medical Center provide the highest standards of care for patients with endocrine disorders and are dedicated to teaching the next generation of endocrinologists.
clinical trial
...

This phase III trial compares early treatment with venetoclax and obinutuzumab versus delayed treatment with venetoclax and obinutuzumab in patients with newly diagnosed high-risk chronic lymphocytic leukemia or small lymphocytic lymphoma. Venetoclax is in a class of medications called B-cell lymphoma-2 (BCL-2) inhibitors. It may stop the growth of cancer cells by blocking Bcl-2, a protein needed for cancer cell survival.
Press Releases
January 25, 2021
Internationally esteemed clinician and health equity researcher, Karen Freund, MD, MPH has been named Physician-in-Chief and Chair of the Department of Medicine at Tufts Medical Center, effective February 1. She will also assume the role of Chair of the Department of Medicine at Tufts University School of Medicine, both effective February 1.